Microarray-based gene expression analysis revealed that T-ALL patients cluster into four major groups based on the aberrant, subtype-specific expression of transcriptional factors TLX1 or TLX3 (HOX family), LYL1 (HLH family), and TAL1 oncogenes [27]. The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.